SCIENCE ADVISORY COUNCIL
Leading Researchers and Clinicians Contributing to the VINEx Mission
The Science Advisory Council (SAC) of VINEx is composed of a diverse group of leading researchers and clinicians who are providing input and advice to ensure that VINEx is developed, executed and monitored with scientific integrity. Viral neuroinvasion is at the intersection of different disciplines, and therefore SAC members bring perspectives from a range of disciplines which are converging to explore how viruses affect the central nervous system and the potential short-and long-term consequences. While the current COVID-19 crisis creates urgency, the initiative aims to have a longer time horizon, and involve COVID-19, other known and unknown coronaviruses, and possibly other viruses with similar pathogenesis.
Membership on the VINEx Science Advisory Council does not constitute or imply an endorsement by a Member of any product or technology under development by Rocket Science Health, or of Rocket Science Health itself.
Scientific integrity is at the center of the VINEx initiative.
Fernanda De Felice, PhD
Adjunct Associate Professor of the Centre for Neuroscience Studies & Department of Biomedical and Molecular Sciences at Queen’s University;
Associate Professor of Biochemistry and Neurosciences at the Federal University of Rio de Janeiro (UFRJ), Brazil.
Marc Desforges, PhD
Specialist in Medical Biology, Virology Lab, CHU Sainte-Justine, Montreal, Quebec.
Renée Douville, PhD
Associate Professor, University of Winnipeg, Department of Biology.
Robyn S. Klein, MD, PhD
The Robert E. and Louise F. Dunn Professor of Medical Sciences;
Associate Dean for Graduate Education in the Division of Biology & Biomedical Sciences; Director at the Center for Neuroimmunology & Neuroinfectious Diseases;
Professor of Medicine, Pathology & Immunology, Neurosciences at Washington University in St. Louis, Missouri.
Douglas P. Munoz, PhD
Canada Research Chair in Neuroscience;
Professor of Biomedical and Molecular Science, Medicine, and Psychology; Queen’s University.
Adrian Owen, PhD
Professor of Cognitive Neuroscience and Imaging,
Department of Physiology and Pharmacology and Department of Psychology,
Lead, COVID-19 Brain Study
Christopher Power, M.D., F.R.C.P(C)
Canada Research Chair in Neurological Infection and Immunity;
Professor of Neurology at the University of Alberta;
Attending physician in the University of Alberta HIV and MS Clinics;
Founding Director of the University of Alberta Multiple Sclerosis Centre.
Alan C. Evans
James McGill Professor of Neurology and Neurosurgery, Psychiatry and Biomedical Engineering;
Researcher in the McConnell Brain Imaging Centre (BIC);
Co-director of the Ludmer Centre for Neuroinformatics and Mental Health;
Principal Investigator of CBRAIN;
Victor Dahdaleh Chair in Neurosciences.
Montreal Neurological Institute – McGill University
David Kaplan, PhD
Senior Scientist, The Hospital for Sick Children, Head, James Fund Laboratories for Neuroblastoma Research, Professor, University of Toronto
Avindra Nath, M.D.
Senior Investigator – Section of Infections of the Nervous System;
Clinical Director – NINDS of the National Institutes of Health (US)
Pierre J. Talbot, PhD
Director - Laboratory of Neuroimmunovirology, INRS-Institut Armand-Frappier, Institut national de la recherche scientifique, Université du Québec.
FROM ROCKET SCIENCE HEALTH
Global Director, VINEx
Rocket Science Health Research and Innovation Manager